Complex mammary tumours in the female dog: A review

Journal of Dairy Research

Volumn 72, Issue SPEC. ISS., 2005, Pages 90-97

  Hellmén, Eva ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Breast; Canine; Genesis; Sarcoma

Indexed keywords

TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; CHEMISTRY; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; MIXED TUMOR; MUTATION; PATHOLOGY; REVIEW; SARCOMA;

ANIMALS; DOG DISEASES; DOGS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MUTATION; NEOPLASMS, COMPLEX AND MIXED; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 24944484971     PISSN: 00220299     EISSN: None     Source Type: Journal    
DOI: 10.1017/S002202990500124X     Document Type: Review

References (79)

1. Adern C, Reynolds C, Ingle JN & Nascimento AG 2004 Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. British Journal of Cancer 91 237-241
2. Akiyoshi T, Uchida K & Tateyama S 2004 Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors. Veterinary Pathology 41 154-163
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ & Clarke MF 2003 Prospective identification of tumorigenic breast cancer cells the USA 100 3983-3988. Erratum in: Proceedings of the National Academy of Sciences of USA 2003 100 6890
4. Al-Nafussi A 1999 Spindle cell tumours of the breast: practical approach to diagnosis. Histopathology 5 1-13
5. Arai K, Nakano H, Shibutani M, Naoi M & Matsuda H 2003 Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors. Veterinary Pathology 40 670-676
6. Argyle DJ & Nasir L 2003 Telomerase: a potential diagnostic and therapeutic tool in canine oncology. Veterinary Pathology 40 1-7
7. Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G & Doglioni C 2001 p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. American Journal of Surgical Pathology 25 1054-1060
8. Blanchard DK, Reynolds CA, Grant CS & Donohue JH 2003 Primary nonphylloides breast sarcomas. American Journal of Surgical Pathology 186 359-361
9. Bot FJ, Sleddens HF & Dinjens WN 1998 Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma. Diagnostic Molecular Pathology 7 295-301
10. Brennan KR & Brown AM 2004 Wnt proteins in mammary development and cancer. Journal of Mammary Gland Biology and Neoplasia 9 119-131
11. Dietrich CU, Pandis N, Rizou H, Petersson C, Bardi G, Qvist H, Apostolikas N, Bohler PJ, Andersen JA, Idvall I, Mitelman F & Heim S 1997 Cytogenetic findings in phyllodes tumors of the breast: karyotypic complexity differentiates between malignant and benign tumors. Human Pathology 28 1379-1382
12. Dunne B, Lee AH, Pinder SE, Bell JA & Ellis IO 2003 An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Human Pathology 4 1009-1015
13. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM & Wicha MS 2004 Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Research 6 R605-R615
14. Espinosa de los Monteros A, Millan MY, Ordas J, Carrasco L, Reymundo C & Martin Las de Mulas J 2002 Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium. Veterinary Pathology 39 247-256
15. Espinosa de los Monteros A, Hellmen E, Ramirez GA, Herraez P, Rodriguez F, Ordas J, Millan Y, Lara A & Martin de las Mulas J 2003 Lipid-rich carcinomas of the mammary gland in seven dogs: clinicopathologic and immunohistochemical features. Veterinary Pathology 40 718-723
16. Foschini MP, Dina RE & Eusebi V 1993 Sarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Seminars in Diagnostic Pathology 10 128-136
17. Foulkes WD 2004 BRCA1 functions as a breast stem cell regulator. Journal of Medical Genetics 41 1-5
18. Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N & Doi K 2000 Cellular proliferative and telomerase activity in canine mammary gland tumors. Veterinary Pathology 37 177-183
19. Gama A, Alves A, Gartner F & Schmitt F 2003 p63: a novel myoepithelial cell marker in canine mammary tissues. Veterinary Pathology 40 412-420
20. Gartner F, Geraldes M, Cassali G, Rema A & Schmitt F 1999 DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis. Veterinary Journal 158 39-47
21. Gatalica Z, Finkelstein S, Lucio E, Tawfik O, Palazzo J, Hightower B & Eyzaguirre E 2001 p53 protein expression and gene mutation in phyllodes tumors of the breast. Pathology Research and Practice 197 183-187
22. Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM & Broughan TA 2000 Phyllodes tumors of the breast: a review of 32 cases. American Surgery 66 360-366
23. Going JJ, Abd El-Monem HM & Craft JA 2001 Clonal origins of human breast cancer. Journal of Pathology 194 406-412
24. Gupta S, Gupta V, Aggarwal PN, Kant R, Khurana N & Mandal AK 2003 Primary chondrosarcoma of the breast: A case report. Indian Journal of Cancer 40 77-79
25. Haga S, Nakayama M, Tatsumi K, Maeda M, Imai S, Umesako S, Yamamoto H, Hilgers J & Sarkar NH 2001 Overexpression of the p53 gene product in canine mammary tumors. Oncology Reports 8 1215-1219
26. Hellmen E & Lindgren A 1989 The expression of intermediate filaments in canine mammary glands and their tumors. Veterinary Pathology 26 420-428
27. Hellmen E & Svensson S 1995 Progression of canine mammary tumours as reflected by DNA ploidy in primary tumours and their metastases. Journal of Comparative Pathology 113 327-342
28. Hellmen E 1996 The pathogenesis of canine mammary tumours. The Cancer Journal 9 282-286
29. Hellmen E, Moller M, Blankenstein MA, Andersson L & Westermark B 2000 Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin. Breast Cancer Research and Treatment 61 197-210
30. Hondermarck H 2003 Breast cancer: when proteomics challenges biological complexity. Molecular and Cellular Proteomics 5 281-291
31. Inoue M & Shiramizu K 1999 Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours. Journal of Comparative Pathology 120 169-175
32. Jolicoeur F, Gaboury LA & Oligny LL 2003 Basal cells of second trimester fetal breasts: immunohistochemical study of myoepithelial precursors. Pediatric Developmental Pathology 6 398-413
33. Jones C, Foschini MP, Chaggar R, Lu YJ, Wells D, Shipley JM, Eusebi V & Lakhani SR 2000 Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Laboratory Investigation 80 831-836
34. Kapiris I, Nasiri N, A'Hern R, Healy V & Gui GP 2001 Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. European Journal of Surgical Oncology 27 723-730
35. Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, Chew KL, Dairkee SH, Jensen RM & Waldman FM 2003 Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Research 63 7167-7175
36. Kurian KM & Al-Nafussi A 2002 Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases. Histopathology 40 58-64
37. Langenbach A, Anderson MA, Dambach DM, Sorenmo KU & Shofer FD 1998 Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996). Journal of the American Animal Hospital Association 34 113-120
38. Lee JS, Kim YB & Min KW 2004 Metaplastic mammary carcinoma with osteoclast-like giant cells: identical point mutation of p53 gene only identified in both the intraductal and sarcomatous components. Virchows Archives 444 194-197
39. Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH & Huang CS 2004 p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. Journal of Pathology 204 131-139
40. Martin de las Mulas J, Ordas J, Millan MY, Chacon F, De Lara M, Espinosa de los Monteros A, Reymundo C & Jover A 2004 Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands. Veterinary Pathology 41 269-272
41. Mayr B, Dressler A, Reifinger M & Feil C 1998 Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. American Journal of Veterinary Research 59 69-78
42. McKenzie CA & Philips J 2002 Malignant phyllodes tumor metastatic to the lung with osteogenic differentiation diagnosed on fine needle aspiration biopsy. A case report. Acta Cytologica 46 718-722
43. Miettinen PJ, Ebner R, Lopez AR & Derynck R 1994 TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. Journal of Cell Biology 127 2021-2036
44. Misdorp W, Else RW, Hellmén E & Lipscomb TP 1999 Histological classification of mammary tumors of the dog and the cat. World Health Organization International Histological Classification of Tumours of Domestic Animals Second series, volume VII. Washington, DC: Armed Forces Institute of Pathology
45. Moller AC & Hellmen E 1994 S100 protein is not specific for myoepithelial cells in the canine mammary gland. Journal of Comparative Pathology 110 49-55
46. Nasir L, Gault E, Campbell S, Veeramalai M, Gilbert D, McFarlane R, Munro A & Argyle DJ 2004 Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT). Gene 336 105-113
47. Nieto A, Perez-Alenza MD, Del Castillo N, Tabanera E, Castano M & Pena L 2003 BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. Journal of Comparative Pathology 128 260-268
48. Oberman HA 1987 Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. American Journal of Surgical Pathology 11 918-929
49. Pandey M, Mathew A, Abraham EK & Rajan B 2004 Primary sarcoma of the breast. Journal of Surgical Oncology 87 121-125
50. Pechoux C, Gudjonsson T, Ronnov-Jessen L, Bissell MJ & Petersen OW 1999 Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Developmental Biology 206 88-99
51. Pereira EM, Maeda SA & Reis-Filho JS 2002 Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer: a challenging diagnosis. Archives of Pathology and Laboratory Medicine 126 723-726
52. Piek E, Moustakas A, Kurisaki A, Heldin CH & ten Dijke P 1999 TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. Journal of Cell Science 112 4557-4568
53. Politi K, Feirt N & Kitajewski J 2004 Notch in mammary gland development and breast cancer. Seminars in Cancer Biology 14 341-347
54. Quintas-Cardama A, Fraga M, Antunez J & Forteza J 2003 Primary extramedullary myeloid tumor of the breast: a case report and review of the literature. Annals of Hematology 82 431-434
55. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F & Schmitt FC 2003 Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Archives 443 122-132
56. Shea B, Reddy V, Abbitt P, Benda R, Douglas V & Wingard J 2004 Granulocytic sarcoma (chloroma) of the breast: a diagnostic dilemma and review of the literature. Breast Journal 10 48-53
57. Shpitz B, Bomstein Y, Sternberg A, Klein E, Tiomkin V, Kaufman A, Groisman G & Bernheim J 2002 Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features. Journal of Surgical Oncology 79 86-92
58. Silver SA & Tavassoli FA 1998 Primary osteogenic sarcoma of the breast: a clinicopathologic analysis of 50 cases. American Journal of Surgical Pathology 22 925-933
59. Silver SA & Tavassoli FA 1999 Osteosarcomatous differentiation in phyllodes tumors. American Journal of Surgical Pathology 23 815-821
60. Smalley M & Ashworth A 2003 Stem cells and breast cancer: A field in transit. Nature Reviews Cancer 3 832-844
61. Souchelnytskyi S 2002 Proteomics in studies of signal transduction in epithelial cells. Journal of Mammary Gland Biology and Neoplasia 7 359-371
62. Susnik B, Jordi Rowe J, Redlich PN, Chitambar C, Chang CC & Kampalath B 2004 A unique collision tumor in breast: invasive ductal carcinoma and mucosa-associated lymphoid tissue lymphoma. Archives of Pathology and Laboratory Medicine 128 99-101
63. Sutter NB & Ostrander EA 2004 Dog-star rising: the canine genetic system. Nature 2004 5 900-910
64. Taccagni G, Rovere E, Masullo M, Christensen L & Eyden B 1997 Myofibrosarcoma of the breast: review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentiation. American Journal of Surgical Pathology 21 489-496
65. Tateyama S, Uchida K, Hidaka T, Hirao M & Yamaguchi R 2001 Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors. Veterinary Pathology 38 703-709
66. Teixeira MR, Qvist H, Bohler PJ, Pandis N & Heim S 1998 Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Genes Chromosomes and Cancer 22 145-151
67. Tsuchida S, Ikemoto S & Tagawa M 2001 Microsatellite polymorphism in intron 14 of the canine BRCA1 gene. Journal of Veterinary Medical Science 63 479-481
68. Van Garderen E, Swennenhuis JF, Hellmen E & Schalken JA 2001 Growth hormone induces tyrosyl phosphorylation of the transcription factors Stat5a and Stat5b in CMT-U335 canine mammary tumor cells. Domestic Animal Endocrinology 20 123-135
69. Van Garderen E & Schalken JA 2002 Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. Molecular and Cellular Endocrinology 197 153-65
70. Van Leeuwen IS, Hellmen E, Cornelisse CJ & Van den Burgh B, Rutteman GR 1996 P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Research 16 3737-3744
71. Veldhoen N, Watterson J, Brash M & Milner J 1999 Identification of tumour-associated and germ line p53 mutations in canine mammary cancer. British Journal of Cancer 81 409-415
72. Vera-Alvarez J, Marigil-Gomez M, Abascal-Agorreta M, Garcia-Prats MD, Lopez-Lopez JI & Perez-Ruiz J 2002 Malignant phyllodes tumor with pleomorphic liposarcomatous stroma diagnosed by fine needle aspiration cytology: a case report. Acta Cytologica 46 50-56
73. Vera-Sempere F & Garcia-Martinez A 2003 Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation. Pathology Research and Practice 199 841-845
74. Wargotz ES & Norris HJ 1989 Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Human Pathology 20 628-635
75. Wargotz ES, Deos PH & Norris HJ 1989 Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Human Pathology 20 732-740
76. Wargotz ES & Norris HJ 1989 Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 64 1490-1499
77. Woolley PV, Gollin SM, Riskalla W, Finkelstein S, Stefanik DF, Riskalla L, Swaney WP, Weisenthal L & McKenna RJ Jr 2000 Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes. Molecular Diagnosis 5 179-190
78. Yazawa M, Okuda M, Setoguchi A, Iwabuchi S, Nishimura R, Sasaki N, Masuda K, Ohno K & Tsujimoto H 2001 Telomere length and telomerase activity in canine mammary gland tumors. American Journal of Veterinary Research 62 1539-1543
79. Zhang RR, Man YG, Vang R, Saenger JS, Barner R, Wheeler DT, Liang CY, Vinh TN & Bratthauer GL 2003 A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Research 5 R151-R156